Literature DB >> 18063811

Forkhead factor, FOXO3a, induces apoptosis of endothelial cells through activation of matrix metalloproteinases.

Hae-Young Lee1, Hyun-Jung You, Joo-Yun Won, Seock-Won Youn, Hyun-Jai Cho, Kyung-Woo Park, Woong-Yang Park, Jeong-Sun Seo, Young-Bae Park, Kenneth Walsh, Byung-Hee Oh, Hyo-Soo Kim.   

Abstract

BACKGROUND: The forkhead factor, FOXO3a, is known to induce apoptosis in endothelial cells (ECs). However, its effects on extracellular matrices (ECM), which are important in EC survival, remained unknown. Here, we evaluated the role of FOXO3a on EC-ECM interaction. METHODS AND
RESULTS: Constitutively active FOXO3a was transduced to human umbilical vein endothelial cells by adenoviral vector (Ad-TM-FOXO3a). Ad-TM-FOXO3a transfection led to dehiscence of ECs from fibronectin-coated plates, resulting in anoikis, which was significantly reversed by matrix metalloproteinase (MMP) inhibitor, GM6001. FOXO3a increased the expression of MMP-3 (stromelysin-1) but decreased the expression of tissue inhibitors of metalloproteinases-1 (TIMP-1), which was associated with increased MMP enzymatic activity in zymography. Pathophysiologic conditions such as serum starvation or heat shock also induced activation of endogenous FOXO3a, leading to activation of MMP-3 and apoptosis, which was reversed by GM6001. Delivery of Ad-TM-FOXO3a to the intraluminal surface in vivo led to EC denudation, disrupted vascular integrity, and impaired endothelium-dependent vasorelaxation.
CONCLUSIONS: Activation of MMPs and possible ECM disruption represent novel mechanisms of FOXO3a-mediated apoptosis in ECs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063811     DOI: 10.1161/ATVBAHA.107.150664

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  24 in total

Review 1.  Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.

Authors:  Mina M Benjamin; Raouf A Khalil
Journal:  Exp Suppl       Date:  2012

Review 2.  Matrix Metalloproteinases as Regulators of Vein Structure and Function: Implications in Chronic Venous Disease.

Authors:  Elisabeth MacColl; Raouf A Khalil
Journal:  J Pharmacol Exp Ther       Date:  2015-08-28       Impact factor: 4.030

Review 3.  Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.

Authors:  Xi Wang; Raouf A Khalil
Journal:  Adv Pharmacol       Date:  2017-09-19

4.  Diphtheria toxin mutant CRM197-mediated transcytosis across blood-brain barrier in vitro.

Authors:  Ping Wang; Yixue Xue; Xiuli Shang; Yunhui Liu
Journal:  Cell Mol Neurobiol       Date:  2010-01-16       Impact factor: 5.046

Review 5.  Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.

Authors:  Arda Kucukguven; Raouf A Khalil
Journal:  Curr Drug Targets       Date:  2013-03       Impact factor: 3.465

6.  Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.

Authors:  Beum-Soo An; Luz E Tavera-Mendoza; Vassil Dimitrov; Xiaofeng Wang; Mario R Calderon; Hui-Jun Wang; John H White
Journal:  Mol Cell Biol       Date:  2010-08-23       Impact factor: 4.272

Review 7.  FoxC1-dependent regulation of vascular endothelial growth factor signaling in corneal avascularity.

Authors:  Hyun-Young Koo; Tsutomu Kume
Journal:  Trends Cardiovasc Med       Date:  2012-08-29       Impact factor: 6.677

8.  Mitochondrial oxidative stress in aortic stiffening with age: the role of smooth muscle cell function.

Authors:  Rui-Hai Zhou; Aleksandr E Vendrov; Igor Tchivilev; Xi-Lin Niu; Kimberly C Molnar; Mauricio Rojas; Jacqueline D Carter; Haiyan Tong; George A Stouffer; Nageswara R Madamanchi; Marschall S Runge
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-12-22       Impact factor: 8.311

9.  AKT2 confers protection against aortic aneurysms and dissections.

Authors:  Ying H Shen; Lin Zhang; Pingping Ren; Mary T Nguyen; Sili Zou; Darrell Wu; Xing Li Wang; Joseph S Coselli; Scott A LeMaire
Journal:  Circ Res       Date:  2012-12-18       Impact factor: 17.367

10.  SIRT1 redresses the imbalance of tissue inhibitor of matrix metalloproteinase-1 and matrix metalloproteinase-9 in the development of mouse emphysema and human COPD.

Authors:  Hongwei Yao; Jae-woong Hwang; Isaac K Sundar; Alan E Friedman; Michael W McBurney; Leonard Guarente; Wei Gu; Vuokko L Kinnula; Irfan Rahman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-09-13       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.